Pengfei Jin

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Jingxin Li, Lihua Hou, Xiling Guo et al. · Nature Medicine · 2022 · 158 citations · Full text

Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

Fengcai Zhu, Pengfei Jin, Tao Zhu et al. · Clinical Infectious Diseases · 2021 · 102 citations · Full text

Comparison of the Effects of Laparoscopic Hernia Repair and Lichtenstein Tension-Free Hernia Repair

Weijun Wang, Jun-zhen Chen, Qian Fang et al. · Journal of Laparoendoscopic & Advanced Surgical Techniques · 2013 · 80 citations

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

Pengfei Jin, Xiling Guo, Wei Chen et al. · PLoS Medicine · 2022 · 44 citations · Full text

STAT3 regulated <i>miR-216a</i> promotes ovarian cancer proliferation and cisplatin resistance

Pengfei Jin, Yan‐Jun Liu, Ruijuan Wang · Bioscience Reports · 2018 · 41 citations · Full text